News
BERLIN, May 26, 2025--(BUSINESS WIRE)--Regulatory News: TME Pharma N.V. (Euronext Growth Paris: ALTME), a clinical-stage biotechnology company focused on developing novel therapies for treatment ...
May 21 (Reuters) - Indian drugmaker Mankind Pharma (MNKI.NS), opens new tab reported a fourth-quarter profit that beat analysts' estimates on Wednesday, driven by strong domestic demand for its ...
Logo: https://mma.prnewswire.com/media/1713483/Galmed_Pharmaceuticals_Logo.jpg View original content:https://www.prnewswire.com/news-releases/galmed-pharmaceuticals ...
Wagh was appointed to the top job about nine months ago, and is among a small group of pharma scions recently elevated to top management roles in their respective companies. Two such announcements ...
As pharma companies try to get more compounded GLP-1 users on branded versions of the drugs, they’re embracing certain ...
TME Pharma N.V. (Euronext Growth Paris: ALTME),a clinical-stage biotechnology company focused on developing novel therapies for treatment of cancer by targeting the tumor microenvironment (TME ...
BERLIN, May 26, 2025--(BUSINESS WIRE)--Regulatory News: TME Pharma N.V. (Euronext Growth Paris: ALTME), a clinical-stage biotechnology company focused on developing novel therapies for treatment of ...
Both countries are trying to navigate U.S. policy challenges for their major pharmaceutical industries, after President Donald Trump this month issued an executive order directing drugmakers to ...
5d
News-Medical.Net on MSNReducing Polypharmacy with Innovative Drug Formulation TechnologiesDiscover how hot melt extrusion supports polypharmacy reduction and novel therapies for stroke and snakebite with expert insights.
RANCHO CUCAMONGA, CA / ACCESS Newswire / May 22, 2025 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Bill Peters, CFO and Jacob Liawatidewi, EVP of Corporate Administration ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results